Closing in October 2009 of a 5.3 million euros A-round of funding complemented by more than 4 million euros of grants and loans from the Walloon Region.
Promethera Biosciences has been founded in February 2009. The company raises 5.3 million euros through series A capital round end October 2009 complemented by 4M€ of loans and grants from the Walloon region. Vesalius Biocapital is the lead investor of the company and is committed to support the company in Round-B.
PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01